• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钌(III)转铁蛋白的光谱表征

Spectral characterization of ruthenium (III) transferrin.

作者信息

Kratz F, Messori L

机构信息

Department of Chemistry, University of Florence, Italy.

出版信息

J Inorg Biochem. 1993 Feb 1;49(2):79-82. doi: 10.1016/0162-0134(93)85017-3.

DOI:10.1016/0162-0134(93)85017-3
PMID:8384244
Abstract

The interaction of ruthenium(III) with human serum transferrin has been investigated through UV/visible and CD spectroscopy. At physiological pH transferrin firmly binds two ruthenium(III) equivalents at the same sites of iron(III). Binding requires the presence of bicarbonate as synergistic anion. Metal uptake from ruthenium(III) nitrilotriacetate is complete within a few minutes; in contrast, uptake from ruthenium(III) chloride does not occur at a significant extent even over a period of days. The chemical properties of the obtained ruthenium/transferrin complex are described.

摘要

通过紫外/可见光谱和圆二色光谱研究了钌(III)与人血清转铁蛋白的相互作用。在生理pH值下,转铁蛋白在铁(III)的相同位点牢固结合两个钌(III)当量。结合需要碳酸氢根作为协同阴离子的存在。从次氮基三乙酸钌(III)中摄取金属在几分钟内即可完成;相比之下,即使经过数天,从氯化钌(III)中摄取的量也不显著。描述了所得钌/转铁蛋白复合物的化学性质。

相似文献

1
Spectral characterization of ruthenium (III) transferrin.钌(III)转铁蛋白的光谱表征
J Inorg Biochem. 1993 Feb 1;49(2):79-82. doi: 10.1016/0162-0134(93)85017-3.
2
The binding properties of two antitumor ruthenium(III) complexes to apotransferrin.两种抗肿瘤钌(III)配合物与脱铁转铁蛋白的结合特性
J Biol Chem. 1994 Jan 28;269(4):2581-8.
3
Periodate modification of human serum transferrin Fe(III)-binding sites. Inhibition of carbonate insertion into Fe(III)- and Cu(II)-chelator-transferrin ternary complexes.人血清转铁蛋白Fe(III)结合位点的高碘酸盐修饰。碳酸根插入Fe(III) - 和Cu(II) - 螯合剂 - 转铁蛋白三元复合物的抑制作用。
J Biol Chem. 1995 May 26;270(21):12404-10. doi: 10.1074/jbc.270.21.12404.
4
Calorimetry of the transfer of Fe(3) from nitrilotriacetate to apotransferrin in the presence and in the absence of bicarbonate.
J Biol Chem. 1974 Jan 25;249(2):407-12.
5
The involvement of bicarbonate in the binding of iron by transferrin.
Biochim Biophys Acta. 1973 Oct 18;322(2):231-3. doi: 10.1016/0005-2795(73)90298-5.
6
Transferrin--interactions of lactoferrin with hydrogen carbonate.转铁蛋白——乳铁蛋白与碳酸氢盐的相互作用
Eur J Biochem. 1997 Oct 1;249(1):149-55. doi: 10.1111/j.1432-1033.1997.t01-1-00149.x.
7
Formation of titanium(IV) transferrin by reaction of human serum apotransferrin with titanium complexes.人血清脱铁转铁蛋白与钛配合物反应生成钛(IV)转铁蛋白。
FEBS Lett. 1999 Jan 15;442(2-3):157-61. doi: 10.1016/s0014-5793(98)01651-2.
8
Structural consequences of binding of UO2(2+) to apotransferrin: can this protein account for entry of uranium into human cells?UO2(2+)与脱铁转铁蛋白结合的结构后果:这种蛋白质能解释铀进入人体细胞的过程吗?
Biochemistry. 2007 Feb 27;46(8):2215-26. doi: 10.1021/bi061945h. Epub 2007 Feb 1.
9
The pH dependent properties of metallotransferrins: a comparative study.金属转运蛋白的pH依赖性特性:一项比较研究。
Biometals. 1997 Oct;10(4):303-13. doi: 10.1023/a:1018328517603.
10
Cobalt and the iron acquisition pathway: competition towards interaction with receptor 1.钴与铁获取途径:对与受体1相互作用的竞争
J Mol Biol. 2008 Jul 25;380(5):900-16. doi: 10.1016/j.jmb.2008.05.045. Epub 2008 May 24.

引用本文的文献

1
Recent Trends in the Development of Novel Metal-Based Antineoplastic Drugs.新型金属抗肿瘤药物的研究进展。
Molecules. 2023 Feb 18;28(4):1959. doi: 10.3390/molecules28041959.
2
Controversial Role of Transferrin in the Transport of Ruthenium Anticancer Drugs.转铁蛋白在钌类抗癌药物转运中的争议性作用。
Biomolecules. 2022 Sep 18;12(9):1319. doi: 10.3390/biom12091319.
3
Gold(III) to Ruthenium(III) Metal Exchange in Dithiocarbamato Complexes Tunes Their Biological Mode of Action for Cytotoxicity in Cancer Cells.三价金到三价钌的金属交换调节二硫代氨基甲酸盐配合物在癌细胞中的细胞毒性的生物作用模式。
Molecules. 2021 Jul 3;26(13):4073. doi: 10.3390/molecules26134073.
4
Synthesis and Assessment of Antibacterial Activities of Ruthenium(III) Mixed Ligand Complexes Containing 1,10-Phenanthroline and Guanide.含1,10-菲咯啉和胍的钌(III)混合配体配合物的合成及其抗菌活性评估
Bioinorg Chem Appl. 2016;2016:3607924. doi: 10.1155/2016/3607924. Epub 2016 Oct 19.
5
Ruthenium-based chemotherapeutics: are they ready for prime time?钌类化疗药物:它们是否已经准备好成为主流?
Cancer Chemother Pharmacol. 2010 May;66(1):1-9. doi: 10.1007/s00280-010-1293-1. Epub 2010 Mar 6.